scispace - formally typeset
D

Daniel Roy

Researcher at Université de Montréal

Publications -  90
Citations -  10314

Daniel Roy is an academic researcher from Université de Montréal. The author has contributed to research in topics: Randomized controlled trial & Aneurysm. The author has an hindex of 24, co-authored 76 publications receiving 7961 citations. Previous affiliations of Daniel Roy include University of Alberta Hospital & Autonomous University of Barcelona.

Papers
More filters
Journal ArticleDOI

Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials

TL;DR: Endovascular thrombectomy is of benefit to most patients with acute ischaemic stroke caused by occlusion of the proximal anterior circulation, irrespective of patient characteristics or geographical location, and will have global implications on structuring systems of care to provide timely treatment.
Journal ArticleDOI

Long-Term Angiographic Recurrences After Selective Endovascular Treatment of Aneurysms With Detachable Coils

TL;DR: Variables determined to be significant predictors of a recurrence included aneurysm size ≥10 mm, treatment during the acute phase of rupture, incomplete initial occlusions, and duration of follow-up, and long-term monitoring of patients treated by endosaccular coiling is mandatory.
Journal ArticleDOI

Endovascular Treatment of Unruptured Aneurysms

TL;DR: Endovascular treatment with GDC for unruptured aneurysms is relatively safe and its role in the prevention of aneurYSmal rupture remains to be determined, preferably by a randomized study.
Journal ArticleDOI

Safety and Efficacy of Endovascular Treatment of Acutely Ruptured Aneurysms

TL;DR: Endovascular treatment of acutely ruptured aneurysms with Guglielmi detachable coils was attempted without clinically significant complication in 92% of the patients.
Journal ArticleDOI

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

Michael D. Hill, +776 more
- 14 Mar 2020 - 
TL;DR: Nerinetide did not improve the proportion of patients achieving good clinical outcomes after endovascular thrombectomy compared with patients receiving placebo, and this trial is registered with ClinicalTrials.gov, NCT02930018.